Related Experiment Video
Updated: Nov 15, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
[Clinical follow-up and genetic analysis of six cases with hypophosphatasia]
1Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.
Insights
Hypophosphatasia (HPP) in Chinese children shows varied outcomes. Infantile HPP has a poor prognosis, while childhood and odonto HPP cases improve with treatment. Genetic testing is key for diagnosis.
Area of Science:
- Pediatrics
- Genetics
- Endocrinology
Background:
- Hypophosphatasia (HPP) is a rare metabolic bone disease.
- Clinical and genetic heterogeneity impacts HPP prognosis.
- Understanding Chinese HPP patient characteristics is crucial.
Purpose of the Study:
- To analyze clinical, genetic, and follow-up data of Chinese HPP patients.
- To correlate genotype with phenotype and outcomes.
- To evaluate diagnostic methods for HPP.
Main Methods:
- Retrospective analysis of six pediatric HPP cases.
- Clinical data collection and follow-up.
- Genetic analysis of the ALPL gene in five patients.
Main Results:
- Reduced serum alkaline phosphatase in all patients.
- Diverse presentations: infantile, childhood, and odonto HPP.
- Ten ALPL gene variations identified, including three novel ones.
- Infantile HPP showed poor prognosis; childhood/odonto HPP improved with intervention.
Conclusions:
- HPP prognosis varies significantly with age of onset.
- Infantile HPP has a poor prognosis, while childhood/odonto HPP have better outcomes.
- Genetic testing of the ALPL gene is essential for definitive HPP diagnosis.
Abstract:
Objective: To analyze the clinical, genetic characteristics and follow-up data of Chinese patients with hypophosphatasia (HPP). Methods: A retrospective analysis was conducted on six children with HPP admitted to the Department of Endocrinology, Genetics and Metabolism in Beijing Children's Hospital from October 2010 to January 2019. Summarized the clinical and follow-up data of all six patients, as well as the pathogenic variants of five children. Results: The serum alkaline phosphatase levels of all six children (five males and one female) were significantly reduced (2-49 U/L). The 6 patients aged from 2 months to 6 years and 4 months, 4 infantile HPP, 1 childhood HIP and 1 odonto HPP. The four patients with infantile HPP presented with anorexia, slow weight gain and hypercalcemia, whereas the one patient with childhood HPP and the other patient with odonto HPP had tooth loss. The patient with childhood HPP also manifested with motor dysfunction. Genetic testing was conducted for five patients and 4 unrelated Chinese families and revealed 10 variations in ALPL gene, including 7 missense variation, 1 insertion variation, 1 frameshift variation, 1 deletion variation.Of which 3 were novel (p.Y28C, p.268, F>L, p.A176V).One of the infantile patients lost follow-up and the other three deceased. The clinical conditions were much improved with medical intervention for patients with childhood, orodonto HPP. Conclusions: While HPP patients with different ages of onset present with common features, the prognosis differ significantly. The prognosis is good for patients with childhood, orodonto HPP and poor for patients with infantile HPP. Genetic testing is the main method for definitive diagnosis.
Related Concept Videos
Lysosomal Hydrolases
Pedigree Analysis

